PRESS-RELEASE ·Filed Mar 3, 2026

BTSG

BrightSpring Health Services, Inc.
NEUTRAL
Impact 5/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release: offering
Actionable Insight • Neutral

Traders should monitor for potential short-term downward pressure from the large share float increase, though the company's share repurchase may mitigate some dilution concerns. The lack of insider selling by the company itself is a neutral signal.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
BTSG ▲ +48.95% at T+60d
NEUTRAL call ✓ call won +48.95% · α vs SPY +38.64% · entry $40.65 → $60.55
Entry anchored
Mar 2, 03:59 PM ET
via exchange tick
T+1d
+3.22%
call +3.22% · α +2.46%
$41.96
settled 7mo ago
T+5d
+1.70%
call +1.70% · α +2.18%
$41.34
settled 7mo ago
T+20d
+4.82%
call +4.82% · α +9.22%
$42.61
settled 6mo ago
T+60d
+48.95%
call +48.95% · α +38.64%
$60.55
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

BrightSpring Health Services announced the pricing of a secondary offering of 20 million shares at $41.15 per share by certain stockholders, including an affiliate of KKR and management. The company will not receive proceeds from the sale but plans to repurchase 1,464,807 shares from the offering at the same price, subject to closing. The move signals shareholder monetization while the company offsets dilution through a concurrent buy-in.

Key Financial Metrics

Deal Value
$823.0M

Key Facts

  • Secondary offering of 20,000,000 shares priced at $41.15 per share by selling stockholders, including KKR affiliate and management
  • BrightSpring is not selling shares and will not receive any proceeds from the offering
  • Company plans to repurchase 1,464,807 shares from the underwriter at the same price, contingent on offering close
  • Offering expected to close on March 4, 2026, subject to customary conditions
  • Goldman Sachs is sole book-running manager

Financial Impact

Selling stockholders will receive $823 million in proceeds (20M shares × $41.15); company will spend ~$60.3 million to repurchase 1.46M shares

dilutionshare_countcash

Risk Factors

  • Potential share price pressure due to increased supply from 20M-share sale
  • Repurchase is not guaranteed — it is conditional on closing and could be delayed or canceled

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3247968
16 reports for BTSG
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +45.59%Feb 27, 2026
Filters
Rows
Reports for BTSG — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
Institutional Cluster
BULLISH ★ 6/10
$60.60 $61.43▲ +1.37%▲ +0.77%$60.25 (−0.58%)
Jul 31, 2026
9w ago
8-K
BULLISH ★ 7/10
$59.71 $59.13▼ −0.97%▼ −3.96%$60.25 (+0.90%)
Jul 31, 2026
9w ago
Press Release
BULLISH ★ 7/10
$59.71 $59.13▼ −0.97%▼ −3.96%$60.25 (+0.90%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$71.58 $60.60▼ −15.34%▼ −17.58%$60.25 (−15.83%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$63.08 $71.58▲ +13.47%▲ +11.58%$60.25 (−4.49%)
Jun 5, 2026
16w ago
Insider Cluster
BEARISH ★ 7/10
$59.22 $70.56▼ −19.15%▼ −17.52%$60.25 (−1.74%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 5/10
$59.22 $70.56▲ +19.15%▲ +17.52%$60.25 (+1.74%)
Jun 5, 2026
16w ago
Insider Cluster
BEARISH ★ 6/10
$59.22 $70.56▼ −19.15%▼ −17.52%$60.25 (−1.74%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 5/10
$57.40 $69.03▲ +20.26%▲ +21.63%$60.25 (+4.97%)
May 1, 2026
22w ago
Press Release
BULLISH ★ 8/10
$52.58 $59.98▲ +14.07%▲ +8.79%$60.25 (+14.59%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 3, 2026